Intended for healthcare professionals


Petition urges GSK and Pfizer to lower price of pneumonia vaccine

BMJ 2016; 353 doi: (Published 29 April 2016) Cite this as: BMJ 2016;353:i2455
  1. Zosia Kmietowicz
  1. The BMJ

The humanitarian charity Médecins Sans Frontières/Doctors Without Borders has delivered a petition of almost 400 000 signatures to the headquarters of GlaxoSmithKline (GSK) in London and Pfizer in New York, demanding that the companies reduce the price of their pneumonia vaccine in developing countries to $5 (£3.45; €4.40) per child.

The petition was delivered to GSK by an …

View Full Text

Log in

Log in through your institution


* For online subscription